#Linkdoc technology ipo registration
#Linkdoc technology ipo Offline

Its main platform, called LinkCare, integrates online and offline channels to assist patients, especially those suffering from cancer, to better manage their illnesses in and out of hospital. But it abruptly scrapped the plan at the 11 th hour as ChinaвЂ™s cybersecurity regulator was targeting a growing number of companies for data security reviews.ДЇounded in 2014 and backed by e-commerce giant AlibabaвЂ™s ( BABA) healthcare arm, Alibaba Health Information Technology ( OTCPK:ALBHF) ( OTCPK:ALBBY) (0241.HK), LinkDoc garners and processes large volumes of medical data for conducting research on new drugs and patient care, with a special focus on cancer treatments.

listings, seeking to raise around $200 million through its IPO. LinkDoc was one of a steady stream of money-losing but fast-growing tech companies to file for U.S. Accordingly, it is increasingly making exceptions and allowing such companies to list, in its own bid to diversify beyond the types of real estate and manufacturing companies that were its traditional bread and butter.ДЄll that said, letвЂ™s return first to LinkDoc, including a review of the bumpy road that brings us to the present, before looking at some of the other listings also in limbo. But Hong Kong has its own obstacles, most notably tough profitability requirements that would normally disqualify a money-losing company like LinkDoc.Д«ut the Hong Kong Stock Exchange has shown growing flexibility in the last few years to accommodate this kind of high-tech, high-growth company. IPO application means LinkDoc has begun the early confidential steps for a Hong Kong IPO that could soon lead to its first public filing. IPOs around the same time and have gone silent since then? At least one such plan appears to still be moving forward, which weвЂ™ll describe shortly.ДЄ potential alternative for LinkDoc and the others could be Hong Kong listings, and itвЂ™s quite possible the formal withdrawal of its U.S. listing now formally dead, the big questions are: What will LinkDoc do next, and whatвЂ™s ahead for the handful of other Chinese companies that had filed for U.S.

#Linkdoc technology ipo registration

вЂњIn light of the current capital markets condition, the company is considering other alternatives and has determined not to proceed at this time with the offering and sale of the securities proposed to be covered by the registration statement,вЂќ LinkDoc said in a brief statement accompanying its withdrawal notice dated April 11. Readers might recall this company had the misfortune of trying to list at the height of a storm centered on the Uber-like DiDi Global ( DIDI ) over data security concerns from ChinaвЂ™s cybersecurity regulator. securities regulator last week it was withdrawing its IPO application first filed last June. The book closed one day earlier than planned on Wednesday, two of the sources said.Medical big data firm LinkDoc Technology Limited ( LDOC) has formally signaled the end of its hopes for a U.S. The deal would have raised $211 million at the upper end of the indicated range. It had planned to sell 10.8 million shares between $17.50 and $19.50 each.

LinkDoc filed for an initial public offering in the United States last month and was due to price its shares after the U.S. The decision to pull the LinkDoc deal was due to the crackdown, the sources said. It is the first known Chinese firm to pull back from its IPO plans since the crackdown began last week with an investigation by ChinaвЂ™s cybersecurity regulator into ride-hailing giant Didi Global Inc just two days after it made its New York debut.Д«eijing said on Tuesday that it would strengthen supervision of all Chinese firms listed offshore, a sweeping regulatory shift that triggered a sell-off in U.S.-listed Chinese stocks. Sources with direct knowledge of the matter have revealed that Chinese medical data group LinkDoc Technology Ltd has shelved plans for an IPO in the United States following BeijingвЂ™s clampdown on overseas listings by domestic firms.